ResMed stock holds firm after July earnings beat
Published on 08/25/2026 at 10:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
ResMed Inc. (US7611521078) stock opened at $232.57 on August 25, 2026, after the company reported $2.95 in earnings per share for the quarter ended June 30, 2026, and $1.46 billion in revenue. The same report showed revenue up 8.6% year over year, while analysts had expected $2.89 in EPS.
Quarterly update
The earnings beat gave the stock a fresh reference point after a quarter that also included a higher dividend. ResMed raised the quarterly payout to $0.66 per share from $0.60, and the annualized dividend now stands at $2.64 per share.
Consensus still looks cautious. MarketBeat's compiled view shows 7 Buy ratings and 10 Hold ratings, with an average target of $239.38 and a Hold consensus.
Trading setup
ResMed's market value was listed at $33.55 billion, with a one-year range of $180.26 to $293.58 and a 50-day average of $208.01. Against that backdrop, the stock's latest print sits above the 50-day line and below the 52-week high.
That spread matters for investors because the quarter-end numbers were strong enough to support the stock's valuation, but not strong enough to pull analyst expectations decisively higher. The gap between the $2.95 EPS result and the $2.89 estimate was only $0.06, which keeps the debate focused on follow-through.
Product context
ResMed's core business centers on sleep therapy and respiratory care devices, including CPAP and bilevel systems, plus masks and related accessories. Those products remain the base of the company's revenue profile and help explain why recurring replacement demand matters so much.
Shares and valuation
As of August 25, 2026, ResMed shares traded at $232.57 in New York. The market cap stood at $33.55 billion, and the stock's 12-month low was $180.26.
Fact box
Company: ResMed Inc.
ISIN: US7611521078
Ticker: RMD
Exchange: NYSE
Price (as of August 25, 2026): $232.57 USD
Market cap: $33.55 billion (as of August 25, 2026)
Sector / Industry: Health Care / Medical Devices
Index membership: S&P 500
